A payment by a company to a close associate of a director that constitutes in substance a gift with no benefit to the company is prima facie an unreasonable director-related transaction under s 588FDA regardless of the company's financial health. The financial condition of the company is not an element of an unreasonable director-related transaction but may be a relevant circumstance under s 588FDA(1)(c)(iv), and its relevance and weight depend on the facts. A natural person who is the directing mind of a company does not become a 'party' to a transaction merely because they caused the company to enter into it; the parties are identified by s 588FDA(1)(a) and (b). Recovery under s 588FF(4) is not capped at the total debts owed to creditors because 'benefit of creditors' includes the costs of proper investigation and administration of the winding up.
The full text is available to signed-in members, including the 23 later cases that cite this judgment.
5 of the 23 citing cases carry a classified treatment. How each court treated it is available to signed-in members.